Your browser doesn't support javascript.
loading
Efficacy and safety of dabrafenib-trametinib in the treatment of unresectable or metastatic melanoma with BRAF V600 mutation: A systematic review and network meta-analysis.
Garzón-Orjuela, Nathaly; Prieto-Pinto, Laura; Lasalvia, Pieralessandro; Herrera, Daniel; Castrillón, Johanna; González-Bravo, Diana; Castañeda-Cardona, Camilo; Rosselli, Diego.
Afiliação
  • Garzón-Orjuela N; Department of Evidence-Based Medicine, NeuroEconomix, Bogotá, Colombia.
  • Prieto-Pinto L; Department of Evidence-Based Medicine, NeuroEconomix, Bogotá, Colombia.
  • Lasalvia P; Department of Evidence-Based Medicine, NeuroEconomix, Bogotá, Colombia.
  • Herrera D; Department of Medical - Oncology Unit, Novartis, Bogotá, Colombia.
  • Castrillón J; Department of Market Access, Novartis, Bogotá, Colombia.
  • González-Bravo D; Department of Evidence-Based Medicine, NeuroEconomix, Bogotá, Colombia.
  • Castañeda-Cardona C; Department of Evidence-Based Medicine, NeuroEconomix, Bogotá, Colombia.
  • Rosselli D; Department of Evidence-Based Medicine, NeuroEconomix, Bogotá, Colombia.
Dermatol Ther ; : e14135, 2020 Aug 05.
Article em En | MEDLINE | ID: mdl-32761749
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Systematic_reviews Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Systematic_reviews Idioma: En Ano de publicação: 2020 Tipo de documento: Article